Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2019

01-08-2019 | Fertility | Clinical trial

Efficacy of a web-based women’s health survivorship care plan for young breast cancer survivors: a randomized controlled trial

Authors: H. Irene Su, Shaylyn Stark, Brian Kwan, Sarah Boles, Diana Chingos, Jennifer Ehren, Jessica R. Gorman, Michael Krychman, Sally A. D. Romero, Jun J. Mao, John P. Pierce, Loki Natarajan

Published in: Breast Cancer Research and Treatment | Issue 3/2019

Login to get access

Abstract

Purpose

Breast cancer survivorship care plans (SCP) have limited content addressing women’s health issues. This trial tested if young breast cancer survivors who receive a web-based, women’s health SCP were more likely to improve on at least one of the four targeted issues (hot flashes, fertility-related concerns, contraception, and vaginal symptoms) compared to attention controls.

Methods

A randomized controlled trial recruited female survivors ages 18–45 at diagnosis, 18–50 at enrollment, completed primary cancer treatment, and had a significant women’s health issue: moderate or higher fertility-related concerns; ≥ 4 hot flashes/day with ≥ 1 of moderate severity; ≥ 1 moderate vaginal atrophy symptoms; or not contracepting/using less effective methods. Survivors underwent stratified, block randomization with equal allocation to intervention and control groups. The intervention group accessed the online SCP; controls accessed curated resource lists. In intention-to-treat analysis, the primary outcome of improvement in at least one issue by 24 weeks was compared by group.

Results

182 participants (86 intervention, 96 control), mean age 40.0 ± 5.9 and 4.4 ± 3.2 years since diagnosis, were randomized. 61 intervention group participants (70.9%) improved, compared to 55 controls (57.3%) (OR 1.82, 95% CI 0.99–3.4, p = 0.057). The following issue-specific improvements were observed in the intervention versus control arms: fertility-related concerns (27.9% vs. 14.6%, OR 2.3, 95% CI 1.1–4.8); hot flashes (58.5% vs. 55.8%, OR 1.1, 95% CI 0.57–2.2); vaginal symptoms (42.5% vs. 40.7%, OR 1.1, 95% CI 0.6–2.0); contraception (50% vs. 42.6%, OR 1.4, 95% CI 0.74–2.5).

Conclusions

In young breast cancer survivors, a novel, web-based SCP did not result in more change in the primary outcome of improvement in at least one of the four targeted women’s health issues, than the attention control condition. The intervention was associated with improved infertility concerns, supporting efficacy of disseminating accessible, evidence-based women’s health information to this population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Su HI, Sammel MD, Green J et al (2010) Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer 116(3):592–599CrossRef Su HI, Sammel MD, Green J et al (2010) Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer 116(3):592–599CrossRef
2.
go back to reference Gold EB, Flatt SW, Pierce JP et al (2006) Dietary factors and vasomotor symptoms in breast cancer survivors: the WHEL Study. Menopause 13(3):423–433CrossRef Gold EB, Flatt SW, Pierce JP et al (2006) Dietary factors and vasomotor symptoms in breast cancer survivors: the WHEL Study. Menopause 13(3):423–433CrossRef
3.
go back to reference Caan BJ, Emond JA, Su HI et al (2012) Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors. J Clin Oncol 30(13):1492–1497CrossRef Caan BJ, Emond JA, Su HI et al (2012) Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors. J Clin Oncol 30(13):1492–1497CrossRef
4.
go back to reference Cvancarova M, Samuelsen SO, Magelssen H et al (2009) Reproduction rates after cancer treatment: experience from the Norwegian radium hospital. J Clin Oncol 27(3):334–343CrossRef Cvancarova M, Samuelsen SO, Magelssen H et al (2009) Reproduction rates after cancer treatment: experience from the Norwegian radium hospital. J Clin Oncol 27(3):334–343CrossRef
5.
go back to reference Safarinejad MR, Shafiei N, Safarinejad S (2013) Quality of life and sexual functioning in young women with early-stage breast cancer 1 year after lumpectomy. Psychooncology 22(6):1242–1248CrossRef Safarinejad MR, Shafiei N, Safarinejad S (2013) Quality of life and sexual functioning in young women with early-stage breast cancer 1 year after lumpectomy. Psychooncology 22(6):1242–1248CrossRef
6.
go back to reference Cook-Andersen H, Flatt SW, Komrokian S, et al (2011) Breast cancer patients have lower rates of contraception use: a prospective cohort study. In: American society of reproductive medicine annual meeting Cook-Andersen H, Flatt SW, Komrokian S, et al (2011) Breast cancer patients have lower rates of contraception use: a prospective cohort study. In: American society of reproductive medicine annual meeting
7.
go back to reference Patel A, Schwarz EB (2012) Society of family P. cancer and contraception: release date May 2012. SFP Guideline #20121. Contraception 86(3):191–198CrossRef Patel A, Schwarz EB (2012) Society of family P. cancer and contraception: release date May 2012. SFP Guideline #20121. Contraception 86(3):191–198CrossRef
8.
go back to reference Yoo C, Yun MR, Ahn JH et al (2013) Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study. Cancer Chemother Pharmacol 72(3):565–575CrossRef Yoo C, Yun MR, Ahn JH et al (2013) Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study. Cancer Chemother Pharmacol 72(3):565–575CrossRef
9.
go back to reference Partridge AH, Gelber S, Peppercorn J et al (2004) Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22(20):4174–4183CrossRef Partridge AH, Gelber S, Peppercorn J et al (2004) Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22(20):4174–4183CrossRef
10.
go back to reference Gorman JR, Malcarne VL, Roesch SC et al (2010) Depressive symptoms among young breast cancer survivors: the importance of reproductive concerns. Breast Cancer Res Treat 123(2):477–485CrossRef Gorman JR, Malcarne VL, Roesch SC et al (2010) Depressive symptoms among young breast cancer survivors: the importance of reproductive concerns. Breast Cancer Res Treat 123(2):477–485CrossRef
11.
go back to reference Letourneau JM, Ebbel EE, Katz PP et al (2012) Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer 118(6):1710–1717CrossRef Letourneau JM, Ebbel EE, Katz PP et al (2012) Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer 118(6):1710–1717CrossRef
12.
go back to reference Howard-Anderson J, Ganz PA, Bower JE et al (2012) Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst 104(5):386–405CrossRef Howard-Anderson J, Ganz PA, Bower JE et al (2012) Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst 104(5):386–405CrossRef
13.
go back to reference Johns C, Seav SM, Dominick SA et al (2016) Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions. Breast Cancer Res Treat 156(3):415–426CrossRef Johns C, Seav SM, Dominick SA et al (2016) Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions. Breast Cancer Res Treat 156(3):415–426CrossRef
14.
go back to reference Seav S, Dominick S, Stepanyuk B et al (2015) Management of sexual dysfunction in breast cancer survivors: a systematic review. Women’s Midlife Health 1:9CrossRef Seav S, Dominick S, Stepanyuk B et al (2015) Management of sexual dysfunction in breast cancer survivors: a systematic review. Women’s Midlife Health 1:9CrossRef
15.
go back to reference Gorman JR, Bailey S, Pierce JP et al (2012) How do you feel about fertility and parenthood? The voices of young female cancer survivors. J Cancer Surviv 6(2):200–209CrossRef Gorman JR, Bailey S, Pierce JP et al (2012) How do you feel about fertility and parenthood? The voices of young female cancer survivors. J Cancer Surviv 6(2):200–209CrossRef
16.
go back to reference Bartula I, Sherman KA (2013) Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations. Breast Cancer Res Treat 141(2):173–185CrossRef Bartula I, Sherman KA (2013) Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations. Breast Cancer Res Treat 141(2):173–185CrossRef
17.
go back to reference Dominick SA, McLean MR, Whitcomb BW et al (2015) Contraceptive practices among female cancer survivors of reproductive age. Obstet Gynecol 126(3):498–507CrossRef Dominick SA, McLean MR, Whitcomb BW et al (2015) Contraceptive practices among female cancer survivors of reproductive age. Obstet Gynecol 126(3):498–507CrossRef
18.
go back to reference Io Medicine (2006) Implementing cancer survivorship care planning: workshop summary. National Academy of Sciences, Washington, DC Io Medicine (2006) Implementing cancer survivorship care planning: workshop summary. National Academy of Sciences, Washington, DC
20.
go back to reference Tan AS, Moldovan-Johnson M, Gray SW et al (2013) An analysis of the association between cancer-related information seeking and adherence to breast cancer surveillance procedures. Cancer Epidemiol Biomark Prev 22(1):167–174CrossRef Tan AS, Moldovan-Johnson M, Gray SW et al (2013) An analysis of the association between cancer-related information seeking and adherence to breast cancer surveillance procedures. Cancer Epidemiol Biomark Prev 22(1):167–174CrossRef
21.
go back to reference Nguyen SK, Ingledew PA (2013) Tangled in the breast cancer web: an evaluation of the usage of web-based information resources by breast cancer patients. J Cancer Educ 28(4):662–668CrossRef Nguyen SK, Ingledew PA (2013) Tangled in the breast cancer web: an evaluation of the usage of web-based information resources by breast cancer patients. J Cancer Educ 28(4):662–668CrossRef
22.
go back to reference Mayer EL, Gropper AB, Neville BA et al (2012) Breast cancer survivors’ perceptions of survivorship care options. J Clin Oncol 30(2):158–163CrossRef Mayer EL, Gropper AB, Neville BA et al (2012) Breast cancer survivors’ perceptions of survivorship care options. J Clin Oncol 30(2):158–163CrossRef
23.
go back to reference Stark SS, Natarajan L, Chingos D et al (2018) Design of a randomized controlled trial on the efficacy of a reproductive health survivorship care plan in young breast cancer survivors. Contemp Clin Trials 77:27–36CrossRef Stark SS, Natarajan L, Chingos D et al (2018) Design of a randomized controlled trial on the efficacy of a reproductive health survivorship care plan in young breast cancer survivors. Contemp Clin Trials 77:27–36CrossRef
24.
go back to reference Davila GW, Singh A, Karapanagiotou I et al (2003) Are women with urogenital atrophy symptomatic? Am J Obstet Gynecol 188(2):382–388CrossRef Davila GW, Singh A, Karapanagiotou I et al (2003) Are women with urogenital atrophy symptomatic? Am J Obstet Gynecol 188(2):382–388CrossRef
25.
go back to reference Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H (2001) Methodologic lessons learned from hot flash studies. J Clin Oncol 19(23):4280–4290CrossRef Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H (2001) Methodologic lessons learned from hot flash studies. J Clin Oncol 19(23):4280–4290CrossRef
26.
go back to reference Gorman JR, Malcarne V, Pierce JP et al (2013) A multidimensional scale to measure the reproductive concerns of young adult cancer survivors. J Cancer Surviv 8:218–228CrossRef Gorman JR, Malcarne V, Pierce JP et al (2013) A multidimensional scale to measure the reproductive concerns of young adult cancer survivors. J Cancer Surviv 8:218–228CrossRef
28.
go back to reference Gorman JR, Roberts SC, Dominick SA et al (2014) A diversified recruitment approach incorporating social media leads to research participation among young adult-aged female cancer survivors. J Adolesc Young Adult Oncol 3(2):59–65CrossRef Gorman JR, Roberts SC, Dominick SA et al (2014) A diversified recruitment approach incorporating social media leads to research participation among young adult-aged female cancer survivors. J Adolesc Young Adult Oncol 3(2):59–65CrossRef
30.
go back to reference Oktay K, Harvey BE, Partridge AH et al (2018) Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 36(19):1994–2001CrossRef Oktay K, Harvey BE, Partridge AH et al (2018) Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 36(19):1994–2001CrossRef
31.
go back to reference Fallat ME, Hutter J (2008) Preservation of fertility in pediatric and adolescent patients with cancer. Pediatrics 121(5):e1461–e1469CrossRef Fallat ME, Hutter J (2008) Preservation of fertility in pediatric and adolescent patients with cancer. Pediatrics 121(5):e1461–e1469CrossRef
32.
go back to reference Network NCC (2019) NCCN Clinical practice guidelines in oncology: adolescent and young adult (AYA) oncology, Version 1.2019, October 3, 2018 Network NCC (2019) NCCN Clinical practice guidelines in oncology: adolescent and young adult (AYA) oncology, Version 1.2019, October 3, 2018
33.
go back to reference Ethics Committee of the American Society for Reproductive Medicine. Electronic address Aao (2018) Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion. Fertil Steril 110(3):380–386CrossRef Ethics Committee of the American Society for Reproductive Medicine. Electronic address Aao (2018) Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion. Fertil Steril 110(3):380–386CrossRef
34.
go back to reference Hadnott TN, Stark SS, Medica ACO et al (2019) Perceived infertility and contraceptive use in the female, reproductive age cancer survivor. Fertil Steril 111:763–771CrossRef Hadnott TN, Stark SS, Medica ACO et al (2019) Perceived infertility and contraceptive use in the female, reproductive age cancer survivor. Fertil Steril 111:763–771CrossRef
35.
go back to reference Anazodo A, Sullivan E, Travaglia J et al (2018) How can we improve oncofertility care for patients? A systematic scoping review of current international practice and models. Hum Reprod Update 25:159–179CrossRef Anazodo A, Sullivan E, Travaglia J et al (2018) How can we improve oncofertility care for patients? A systematic scoping review of current international practice and models. Hum Reprod Update 25:159–179CrossRef
36.
go back to reference Barnett AG, van der Pols JC, Dobson AJ (2005) Regression to the mean: what it is and how to deal with it. Int J Epidemiol 34(1):215–220CrossRef Barnett AG, van der Pols JC, Dobson AJ (2005) Regression to the mean: what it is and how to deal with it. Int J Epidemiol 34(1):215–220CrossRef
37.
go back to reference Secura GM, Madden T, McNicholas C et al (2014) Provision of no-cost, long-acting contraception and teenage pregnancy. N Engl J Med 371(14):1316–1323CrossRef Secura GM, Madden T, McNicholas C et al (2014) Provision of no-cost, long-acting contraception and teenage pregnancy. N Engl J Med 371(14):1316–1323CrossRef
38.
go back to reference Jacobsen PB, DeRosa AP, Henderson TO et al (2018) Systematic review of the impact of cancer survivorship care plans on health outcomes and health care delivery. J Clin Oncol 36(20):2088–2100CrossRef Jacobsen PB, DeRosa AP, Henderson TO et al (2018) Systematic review of the impact of cancer survivorship care plans on health outcomes and health care delivery. J Clin Oncol 36(20):2088–2100CrossRef
39.
go back to reference Nicolaije KA, Ezendam NP, Vos MC et al (2015) Impact of an automatically generated cancer survivorship care plan on patient-reported outcomes in routine clinical practice: longitudinal outcomes of a pragmatic. Cluster Randomized Trial. J Clin Oncol 33(31):3550–3559PubMed Nicolaije KA, Ezendam NP, Vos MC et al (2015) Impact of an automatically generated cancer survivorship care plan on patient-reported outcomes in routine clinical practice: longitudinal outcomes of a pragmatic. Cluster Randomized Trial. J Clin Oncol 33(31):3550–3559PubMed
40.
go back to reference Maly RC, Liang LJ, Liu Y et al (2017) Randomized controlled trial of survivorship care plans among low-income, predominantly latina breast cancer survivors. J Clin Oncol 35(16):1814–1821CrossRef Maly RC, Liang LJ, Liu Y et al (2017) Randomized controlled trial of survivorship care plans among low-income, predominantly latina breast cancer survivors. J Clin Oncol 35(16):1814–1821CrossRef
41.
go back to reference Emery JD, Jefford M, King M et al (2017) ProCare Trial: a phase II randomized controlled trial of shared care for follow-up of men with prostate cancer. BJU Int 119(3):381–389CrossRef Emery JD, Jefford M, King M et al (2017) ProCare Trial: a phase II randomized controlled trial of shared care for follow-up of men with prostate cancer. BJU Int 119(3):381–389CrossRef
42.
go back to reference Boekhout AH, Vincent AD, Dalesio OB et al (2011) Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 29(29):3862–3868CrossRef Boekhout AH, Vincent AD, Dalesio OB et al (2011) Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 29(29):3862–3868CrossRef
43.
go back to reference Brothers BM, Easley A, Salani R et al (2013) Do survivorship care plans impact patients’ evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol 129(3):554–558CrossRef Brothers BM, Easley A, Salani R et al (2013) Do survivorship care plans impact patients’ evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol 129(3):554–558CrossRef
44.
go back to reference Hudson MM, Leisenring W, Stratton KK et al (2014) Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial. J Clin Oncol 32(35):3974–3981CrossRef Hudson MM, Leisenring W, Stratton KK et al (2014) Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial. J Clin Oncol 32(35):3974–3981CrossRef
45.
go back to reference Smith KC, Tolbert E, Hannum SM et al (2016) Comparing web-based provider-initiated and patient-initiated survivorship care planning for cancer patients: a randomized controlled trial. JMIR Cancer 2(2):e12CrossRef Smith KC, Tolbert E, Hannum SM et al (2016) Comparing web-based provider-initiated and patient-initiated survivorship care planning for cancer patients: a randomized controlled trial. JMIR Cancer 2(2):e12CrossRef
46.
go back to reference Fulda KG, Hahn KA, Young RA et al (2011) Recruiting practice-based Research Network (PBRN) physicians to be research participants: lessons learned from the North Texas (NorTex) needs assessment study. J Am Board Fam Med 24(5):610–615CrossRef Fulda KG, Hahn KA, Young RA et al (2011) Recruiting practice-based Research Network (PBRN) physicians to be research participants: lessons learned from the North Texas (NorTex) needs assessment study. J Am Board Fam Med 24(5):610–615CrossRef
Metadata
Title
Efficacy of a web-based women’s health survivorship care plan for young breast cancer survivors: a randomized controlled trial
Authors
H. Irene Su
Shaylyn Stark
Brian Kwan
Sarah Boles
Diana Chingos
Jennifer Ehren
Jessica R. Gorman
Michael Krychman
Sally A. D. Romero
Jun J. Mao
John P. Pierce
Loki Natarajan
Publication date
01-08-2019
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2019
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-019-05260-6

Other articles of this Issue 3/2019

Breast Cancer Research and Treatment 3/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine